Comparison of clinical and laboratory features and treatment responses in patients with clinically amyopathic juvenile dermatomyositis and classical juvenile dermatomyositis

The aim of this study was to compare the clinical and laboratory features, treatment choices and responses, and outcomes between patients with clinically amyopathic juvenile dermatomyositis (CAJDM) and classical juvenile dermatomyositis (JDM).

[1]  M. Goldust,et al.  Adult and juvenile dermatomyositis treatment , 2022, Journal of cosmetic dermatology.

[2]  T. Tebeică,et al.  Anti-MDA5 Amyopathic Dermatomyositis—A Diagnostic and Therapeutic Challenge , 2022, Life.

[3]  Meiping Lu,et al.  Juvenile dermatomyositis: advances in clinical presentation, myositis-specific antibodies and treatment , 2019, World Journal of Pediatrics.

[4]  L. Wedderburn,et al.  Juvenile dermatomyositis: novel treatment approaches and outcomes , 2018, Current opinion in rheumatology.

[5]  I. Targoff,et al.  Features distinguishing clinically amyopathic juvenile dermatomyositis from juvenile dermatomyositis , 2018, Rheumatology.

[6]  G. Shaddick,et al.  Autoantibodies in juvenile-onset myositis: Their diagnostic value and associated clinical phenotype in a large UK cohort , 2017, Journal of autoimmunity.

[7]  C. Selmi,et al.  Idiopathic Inflammatory Myopathies: an Update on Classification and Treatment with Special Focus on Juvenile Forms , 2017, Clinical Reviews in Allergy & Immunology.

[8]  L. Rider,et al.  Childhood Arthritis and Rheumatology Research Alliance consensus clinical treatment plans for juvenile dermatomyositis with skin predominant disease , 2017, Pediatric Rheumatology.

[9]  O. Kasapcopur,et al.  Juvenile dermatomyositis: a tertiary center experience , 2017, Clinical Rheumatology.

[10]  N. Wulffraat,et al.  Consensus-based recommendations for the management of juvenile dermatomyositis , 2016, Annals of the rheumatic diseases.

[11]  L. Wedderburn,et al.  Comparing and contrasting clinical and serological features of juvenile and adult-onset myositis: implications for pathogenesis and outcomes , 2015, Current opinion in rheumatology.

[12]  D. Fiorentino,et al.  Amyopathic Dermatomyositis: Definitions, Diagnosis, and Management , 2014, Current Rheumatology Reports.

[13]  V. Ziaee,et al.  Clinical course and outcomes of Iranian children with juvenile dermatomyositis and polymyositis , 2014, Clinical Rheumatology.

[14]  B. Feldman,et al.  Juvenile dermatomyositis and other idiopathic inflammatory myopathies of childhood , 2008, The Lancet.

[15]  P. Gerami,et al.  A systematic review of juvenile‐onset clinically amyopathic dermatomyositis , 2007, The British journal of dermatology.

[16]  P. Gerami,et al.  A systematic review of adult-onset clinically amyopathic dermatomyositis (dermatomyositis siné myositis): a missing link within the spectrum of the idiopathic inflammatory myopathies. , 2006, Journal of the American Academy of Dermatology.

[17]  P. Lachenbruch,et al.  Validation and clinical significance of the Childhood Myositis Assessment Scale for assessment of muscle function in the juvenile idiopathic inflammatory myopathies. , 2004, Arthritis and rheumatism.

[18]  R. Sontheimer.  Would a new name hasten the acceptance of amyopathic dermatomyositis (dermatomyositis siné myositis) as a distinctive subset within the idiopathic inflammatory dermatomyopathies spectrum of clinical illness? , 2002, Journal of the American Academy of Dermatology.

[19]  D. Symmons,et al.  The incidence of juvenile dermatomyositis: results from a nation-wide study. , 1995, British journal of rheumatology.

[20]  A. Bohan,et al.  Polymyositis and dermatomyositis (second of two parts). , 1975, The New England journal of medicine.

[21]  A. Bohan,et al.  Polymyositis and dermatomyositis (second of two parts). , 1975 .

[22]  Dominic O. Co,et al.  How Often are Pediatric Patients with Clinically Amyopathic Dermatomyositis Truly Amyopathic? , 2017, Pediatric dermatology.